medigraphic.com
ISSN 1561-3062 (Electronic)

2012, Number 1

<< Back Next >>

Revista Cubana de Obstetricia y Ginecología 2012; 38 (1)

A long-term analysis of the conservative surgery behavior in breast cancer

Hernández DD, Díaz MO, Abreu VMR

Language: Spanish
References: 42
Page: 117-133
PDF size: 248.43 Kb.


ABSTRACT

Introduction: In past years the conservative surgery became consolidated as a valid procedure in treatment of a determined group of breast cancer patients, thus allows to achieve a satisfactory local control with a lesser level of mutilation, neither modifying the survival nor distant metastasis index from a distance.
Objective: To determine the results of conservative surgery of breast cancer according to the variables selected during 1991-2009.
Methods: a longitudinal and retrospective study was conducted in women diagnosed and treated due to breast cancer who underwent conservative surgery (n= 77), fulfilling the established inclusion and exclusion criteria. Data descriptive analysis was performed by absolute and relative frequency distribution. The estimation of global survival curves and free of relapse was performed by Kaplan-Meier method.
Results: The 40 to 59 age group was the predominant one for a 67.6 %. Only the 10.4% of patients had first line positive backgrounds of breast cancer. The IIA clinical stage predominates with a 54.5 % and the more frequent histological type, the infiltrating ductal carcinoma for a 84.4 %. The 5-years global survival for our patients was of 95 % and the interval free relapse was of 87.5 %.
Conclusions: Our results not differ from those found in studies at world level.


REFERENCES

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-917.

  2. Schopper D, de Wolf C: How effective are breast cancer screening programmes by mammography? Review of the current evidence. Eur J Cancer. 2009;45:1916-23.

  3. Thorat Mangesh A, Rangole Ashvin, Nadkarni Mandar S, Parmar Vani, Badwe Rajendra A. Revision Surgery for Breast Cancer. Cancer. Supplement October 15, 2008;113(8).

  4. Adams C, Grey N, Magrath I, Miller A, Torode J. The World Cancer Declaration: is the world catching up? Lancet Oncol. 2010;11:1018-20.

  5. Pike MC, Spicer DV, Dalimoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cáncer risk. Epidemiol Rev. 1991;15:48-65.

  6. Aziz Z, Iqbal J, Akram M, Anderson BO. Worsened oncologic outcomes for women of lower socio-economic status (SES) treated for locally advanced breast cancer (LABC) in Pakistan. Breast. 2010;19:38-43.

  7. Kerr DJ, Midgley R. Can we treat cancer for a dollar a day? Guidelines for lowincome countries. N Engl J Med. 2010;363:801-03.

  8. Paolo Boffetta, Philippe Autier. Is breast cancer associated with tobacco smoking? BMJ. 2011;342:d1093.

  9. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev. 1993;15:233-43.

  10. Bruzzi P, Negri E, La Vecchia C. Short term increase in risk of breast cancer risk in a large cohort of woman. Am J Epidemiol. 1998;147:636-43.

  11. Pike MC, Krailo MD, Henderson BS, Casagrande JT, Hoel DG. Hormonal risk factors, "breast tissue age", and the age-incidence of breast cancer. Nature. 1983;303:767-70.

  12. Russo J, Tay LK, Russo IK. Differentiation of the mammary gland and susceptibility to carcinogénesis. Breast Cancer Res Treat. 1982;2:5-73.

  13. Rosner B, Colditz G. Extended mathematical model of breast cancer incidence in the Nurses´ Health Study. J Natl Cancer Inst. 1996;88:359-64.

  14. La Vecchia C, Negri E, Boyle P. Reproductive factors and breast cáncer: an overview. Soz Praventivmed. 1989;34:101-7.

  15. Lane-Claypon JE. A further report on cancer of the breast, with special reference to its associated antecedent conditions. London: Ministry of Health; 1926.

  16. Romieu J, Hernández-Ávila M, Lazcano E, López L, Romero-Jaime R. Breast cáncer and lactation history in Mexican women. Am J Epidemiol. 1996;132:17-26.

  17. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet. 1996;47:1713-27.

  18. Colditz GA, Stampfer MJ, Willett WC. Reproducibility and validity of selfreported menopausal status in a prospective cohort study. Am J Epidemiol. 1987;126:319-25.

  19. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet. 1996;347(9017):1713-27.

  20. Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2009;101:48-60.

  21. Xue F, Michels KB: Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr. 2007;86:s823-35.

  22. Pisani P. Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. Arch Physiol Biochem. 2008;114:63-70.

  23. Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, Crosignani P, et al. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: A nested case-control study. Nutr Metab Cardiovasc Dis; 2009.

  24. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci. 2001;98(19):10869-74.

  25. Adami HO, Hansen J, Jung B, Rimsten A. Characteristics of familial breast cancer in Sweden absence of relation to age and unilateral versus bilateral disease. Cancer. 1981;48:1688.

  26. Masood S, Vass L, Ibarra JA Jr. Breast pathology guideline. implementation in low- and middle-income countries. Cancer. 2008;113 (suppl 8):2297-304.

  27. Del Casar JM, Martin A, Garcia C, Corte MD, Alvarez A, Junquera S, et al. Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinicopathological characteristics, biological features and prognosis. Eur J Obstet Gynecol Reprod Biol. 2008;141(2):147-52.

  28. Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson DA, et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet; 2008.

  29. Rozas R, Rivas L, Carayhua D. Cáncer de mama en el Hospital Nacional "Daniel Alcides Carrión-Callao". Aspectos anatomopatológicos y epidemiológicos. Acta Cancerológica. 2002;31:89-92.

  30. Thorat MA, Rangole A, Nadkarni MS, Parmar V, Badwe RA. Revision surgery for breast cancer: single-institution experience. Cancer. 2008;113(suppl 8):2347-52.

  31. Newton M, Bird P. Impact of parallel anesthesia and surgical provider training in sub-Saharan Africa: a model for a resource-poor setting. World J Surg. 2010;34:445-52.

  32. Dick AW, Sorbero MS, Ahrendt GM, Hayman JA, Gold HT, Schiffhauer L, et al. Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons. J Natl Cancer Inst. 2011;103:92-104.

  33. Sakr RA, Poulet B, Kaufman GJ, Nos C, Clough KB. Clear margins for invasive lobular carcinoma: a surgical challenge. Eur J Surg Oncol. 2011;37:350-6.

  34. Olson TP, Harter J, Munoz A, Mahvi DM, Breslin T. Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence. Ann Surg Oncol. 2007;14:2953-60.

  35. Ribelles N, Torres E, Alba E. Factores pronósticos en cáncer de mama Rev Cancer 2002;16(4):127-37.

  36. Van Nes JG, Putter H, Julien JP, Tubiana-Hulin M, van de Vijver MJ, Bogaerts J, et al. Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902. Breast Cancer Res Treat. 2009;115:101-13.

  37. Cancello G, Maisonneuve P, Rotmensz N, Viale G, Mastropasqua MG, Pruneri G, et al. Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (< 35 years) with operable breast cancer. Ann Oncol. 2010;21:1974-81.

  38. Smid M, Wang Y, Zhang Y, Sieuwerts AM, Yu J, Klijn JG, et al. Subtypes of breast cancer show preferential site of relapse. Cancer Res. 2008;68:3108-14.

  39. Koscielny S, Tubiana M, Le M. Breast cancer: relationship between the size of the primary tumor and the probability of metastatic dissemination. Br J Cancer. 1984;49:709.

  40. Koscielny S, Le M, Tubiana M. The natural history of human breast cancer: the relationship between involvement of axillary lymph nodes and the initiation of distant metastases. Br J Cancer. 1989;59:775.

  41. Sánchez Varela I. Cirugía Conservadora en Cáncer de Mama [tesis]. La Habana: Facultad Manuel Fajardo; 1997.

  42. Stuart-Harris R, Caldas C, Pinder SE, Pharoah P. Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825




2020     |     www.medigraphic.com